HK1026855A1 - Ganglioside immunostimulating complexes and uses thereof - Google Patents

Ganglioside immunostimulating complexes and uses thereof

Info

Publication number
HK1026855A1
HK1026855A1 HK00106085A HK00106085A HK1026855A1 HK 1026855 A1 HK1026855 A1 HK 1026855A1 HK 00106085 A HK00106085 A HK 00106085A HK 00106085 A HK00106085 A HK 00106085A HK 1026855 A1 HK1026855 A1 HK 1026855A1
Authority
HK
Hong Kong
Prior art keywords
ganglioside
immunostimulating complexes
immunostimulating
complexes
ganglioside immunostimulating
Prior art date
Application number
HK00106085A
Other languages
English (en)
Inventor
Cox John Cooper
Ronnberg Bengt John Lennart
Sjolander Sigrid Elisabet
Original Assignee
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Ltd filed Critical Csl Ltd
Publication of HK1026855A1 publication Critical patent/HK1026855A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001186—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
HK00106085A 1997-06-12 2000-09-26 Ganglioside immunostimulating complexes and uses thereof HK1026855A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO7329A AUPO732997A0 (en) 1997-06-12 1997-06-12 Ganglioside immunostimulating complexes and uses thereof
PCT/AU1998/000453 WO1998056420A1 (en) 1997-06-12 1998-06-12 Ganglioside immunostimulating complexes and uses thereof

Publications (1)

Publication Number Publication Date
HK1026855A1 true HK1026855A1 (en) 2000-12-29

Family

ID=3801620

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106085A HK1026855A1 (en) 1997-06-12 2000-09-26 Ganglioside immunostimulating complexes and uses thereof

Country Status (10)

Country Link
US (1) US6814981B1 (xx)
EP (1) EP1019087B1 (xx)
JP (1) JP2002504101A (xx)
AU (1) AUPO732997A0 (xx)
CA (1) CA2293439A1 (xx)
DE (1) DE69838757T2 (xx)
HK (1) HK1026855A1 (xx)
NZ (1) NZ501641A (xx)
WO (1) WO1998056420A1 (xx)
ZA (1) ZA985140B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713942B2 (en) 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
EP2011517A1 (en) * 2001-04-04 2009-01-07 Nordic Vaccine Technology A/S Polynucleotide binding complexes comprising sterols and saponin
EP1545605B8 (en) * 2002-10-02 2010-05-26 Nordic Vaccine A/S Composition for vaccination
CN101563090B (zh) * 2006-11-20 2013-01-02 杜科姆公司 包含南美皂皮树皂苷的含脂质颗粒用于治疗癌症的用途
JP2008214241A (ja) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 免疫調節剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
IE912535A1 (en) 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
IL105503A (en) * 1992-04-28 1999-05-09 Astra Ab Carbon peptide couplets capable of eliciting an immune response of T cells
AU685776B2 (en) * 1993-01-22 1998-01-29 Sloan-Kettering Institute For Cancer Research Ganglioside-KLH conjugate vaccines with QS-21
EP0657471B1 (en) * 1993-12-09 2001-10-24 Centro de Inmunologia Molecular Anti ganglioside monoclonal antibodies and their use in the specific active immunotherapy of malignant tumours
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
US6218166B1 (en) * 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини

Also Published As

Publication number Publication date
EP1019087A1 (en) 2000-07-19
AUPO732997A0 (en) 1997-07-03
EP1019087B1 (en) 2007-11-21
DE69838757D1 (de) 2008-01-03
WO1998056420A1 (en) 1998-12-17
EP1019087A4 (en) 2003-08-06
DE69838757T2 (de) 2008-10-30
JP2002504101A (ja) 2002-02-05
ZA985140B (en) 1999-01-07
CA2293439A1 (en) 1998-12-17
NZ501641A (en) 2000-12-22
US6814981B1 (en) 2004-11-09

Similar Documents

Publication Publication Date Title
GB2325840B (en) Heater-sensor complex
DE69530493D1 (en) Ablationsgerät
GB9414164D0 (en) Drillclamp
ZA9510671B (en) Thienopyridone
HK1026855A1 (en) Ganglioside immunostimulating complexes and uses thereof
ZA953003B (en) Connection arrangement
GB2292487B (en) Connection arrangement
GB9405352D0 (en) Henry
GB2286644A8 (en) Connection
EP0706238A3 (en) Connection arrangement
GB9403047D0 (en) Top-Tee
LTIP2071A (en) Immunostimulating agent
ZA958599B (en) Panel-like structure
GB9714582D0 (en) Complex
GB9409634D0 (en) Connecting means
ZA946119B (en) Panels
GB9413539D0 (en) Case
EP0706239A3 (en) Connection device
GB9724706D0 (en) Gyimapet companion
AU122897S (en) Cannelloni shape
PL100874U1 (en) Shape
GB9404277D0 (en) Telememo
AU125944S (en) Campervan
GB9402264D0 (en) Bugrax
HU9403527D0 (en) Advertisement-board

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110612